Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant.
about
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusVaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humansNasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization.Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older.Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccineMeta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus.Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepaticaDiscordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.Influenza A virus matrix protein 1-specific human CD8+ T-cell response induced in trivalent inactivated vaccine recipients.New adjuvants: EU regulatory developments.Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.Correlates of vaccine protection from influenza and its complications.Carbohydrate-based vaccine adjuvants - discovery and development.Liposomal adjuvants for human vaccines.QS-21 enhances the early antibody response to oil adjuvant foot-and-mouth disease vaccine in cattle.Challenges in improving influenza vaccine protection in the elderly.Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant.Adjuvanted influenza vaccines
P2860
Q28084005-E138DDE7-1147-4A61-A7A8-671865C52398Q30354893-1AE66709-C6C0-4DEB-AABF-64A844CE4148Q33725145-C6883A1E-CADC-4850-A8BD-BC07E560851FQ34067461-F0099870-ED74-4C70-BAD7-866D797C5E8CQ35866636-DBF96225-5421-4173-BA20-0F427BA056BCQ36009558-9909499B-1058-4C15-917B-D8B40CC4C1DCQ36422549-C259BB74-2125-42C5-A01A-237CECADED43Q36447711-DF13B0FE-3645-430E-8724-61F3AAC7E0FFQ36737727-F7483727-D667-4161-A6B7-AF3385663BA0Q36898670-AA668706-4E67-4BD5-AF1C-E87A36D22EBFQ36968305-0CEFAD6D-D05A-4C4F-A178-934D2BA16A45Q37423256-53530386-7169-43DF-B649-4F162963E5C2Q37976539-19A60BC3-CFEA-4FEE-8310-3117277D2E57Q38587300-A68C1FA3-DA34-47F2-8774-31DFAE59D452Q38729260-0CD35250-CBEF-4686-A568-DD6BC465E75DQ40636746-1E7406CB-2DC1-434F-A4E6-54D2971D3A75Q43479726-E845E92E-C0F2-41FF-BA00-5FC5DE4780F5Q54430596-591CBD17-E4FF-4C8A-9020-A018B17EED55Q57094841-844A87D2-5909-4D04-8B22-AB369C460182
P2860
Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Humoral and cell-mediated immu ...... with or without QS21 adjuvant.
@ast
Humoral and cell-mediated immu ...... with or without QS21 adjuvant.
@en
type
label
Humoral and cell-mediated immu ...... with or without QS21 adjuvant.
@ast
Humoral and cell-mediated immu ...... with or without QS21 adjuvant.
@en
prefLabel
Humoral and cell-mediated immu ...... with or without QS21 adjuvant.
@ast
Humoral and cell-mediated immu ...... with or without QS21 adjuvant.
@en
P2093
P2860
P1433
P1476
Humoral and cell-mediated immu ...... with or without QS21 adjuvant.
@en
P2093
P2860
P304
P356
10.1016/J.VACCINE.2007.01.073
P407
P577
2007-01-24T00:00:00Z